William Mark Erwin

1.8k total citations
34 papers, 1.3k citations indexed

About

William Mark Erwin is a scholar working on Pathology and Forensic Medicine, Pharmacology and Surgery. According to data from OpenAlex, William Mark Erwin has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pathology and Forensic Medicine, 17 papers in Pharmacology and 12 papers in Surgery. Recurrent topics in William Mark Erwin's work include Spine and Intervertebral Disc Pathology (28 papers), Musculoskeletal pain and rehabilitation (17 papers) and Osteoarthritis Treatment and Mechanisms (6 papers). William Mark Erwin is often cited by papers focused on Spine and Intervertebral Disc Pathology (28 papers), Musculoskeletal pain and rehabilitation (17 papers) and Osteoarthritis Treatment and Mechanisms (6 papers). William Mark Erwin collaborates with scholars based in Canada, Switzerland and United States. William Mark Erwin's co-authors include Robert D. Inman, Michael G. Fehlings, Joseph R. Dettori, Spyridon K. Karadimas, Diana Islam, Ajay Matta, Keith Ashman, Florence W. L. Tsui, David E. Isenman and Greg Kawchuk and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Spine.

In The Last Decade

William Mark Erwin

34 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William Mark Erwin Canada 18 1.1k 674 496 204 185 34 1.3k
Robert A. Hartman United States 18 1.0k 1.0× 450 0.7× 677 1.4× 187 0.9× 190 1.0× 33 1.3k
Markus Kroeber Germany 19 655 0.6× 691 1.0× 465 0.9× 241 1.2× 87 0.5× 37 1.3k
Devina Purmessur United States 24 1.4k 1.3× 490 0.7× 1.1k 2.1× 272 1.3× 262 1.4× 41 1.7k
D. C. Jaffray United Kingdom 12 1.1k 1.0× 579 0.9× 818 1.6× 129 0.6× 225 1.2× 17 1.4k
N Chiverton United Kingdom 12 722 0.7× 349 0.5× 515 1.0× 126 0.6× 162 0.9× 27 961
Yoichi Aota Japan 21 1.0k 1.0× 861 1.3× 738 1.5× 73 0.4× 95 0.5× 49 1.5k
Jayesh Trivedi United Kingdom 12 792 0.7× 609 0.9× 437 0.9× 117 0.6× 114 0.6× 33 1.1k
Johanna Virri Finland 18 978 0.9× 483 0.7× 774 1.6× 70 0.3× 113 0.6× 21 1.1k
Yasuo Kokubo Japan 25 848 0.8× 1.0k 1.5× 320 0.6× 93 0.5× 199 1.1× 68 1.5k
John C. Y. Leong Hong Kong 14 985 0.9× 482 0.7× 800 1.6× 93 0.5× 182 1.0× 21 1.3k

Countries citing papers authored by William Mark Erwin

Since Specialization
Citations

This map shows the geographic impact of William Mark Erwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Mark Erwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Mark Erwin more than expected).

Fields of papers citing papers by William Mark Erwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Mark Erwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Mark Erwin. The network helps show where William Mark Erwin may publish in the future.

Co-authorship network of co-authors of William Mark Erwin

This figure shows the co-authorship network connecting the top 25 collaborators of William Mark Erwin. A scholar is included among the top collaborators of William Mark Erwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Mark Erwin. William Mark Erwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Matta, Ajay, et al.. (2022). A Single Injection of NTG-101 Reduces the Expression of Pain-Related Neurotrophins in a Canine Model of Degenerative Disc Disease. International Journal of Molecular Sciences. 23(10). 5717–5717. 7 indexed citations
3.
Matta, Ajay, et al.. (2021). A comparative study of mesenchymal stem cell transplantation and NTG-101 molecular therapy to treat degenerative disc disease. Scientific Reports. 11(1). 14804–14804. 11 indexed citations
4.
Matta, Ajay & William Mark Erwin. (2020). Injectable Biologics for the Treatment of Degenerative Disc Disease. Current Reviews in Musculoskeletal Medicine. 13(6). 680–687. 17 indexed citations
5.
Matta, Ajay, Martha Funabashi, Greg Kawchuk, et al.. (2018). NTG-101: A Novel Molecular Therapy that Halts the Progression of Degenerative Disc Disease. Scientific Reports. 8(1). 16809–16809. 23 indexed citations
6.
Matta, Ajay, et al.. (2017). Molecular Therapy for Degenerative Disc Disease: Clues from Secretome Analysis of the Notochordal Cell-Rich Nucleus Pulposus. Scientific Reports. 7(1). 45623–45623. 62 indexed citations
7.
Houweling, Tanja A. J., et al.. (2016). A commentary on the implications of medication prescription rights for the chiropractic profession. Chiropractic & Manual Therapies. 24(1). 33–33. 10 indexed citations
8.
Müller, Sebastian, Xiaomei Wang, Ajay Matta, et al.. (2016). Notochordal cell conditioned medium (NCCM) regenerates end-stage human osteoarthritic articular chondrocytes and promotes a healthy phenotype. Arthritis Research & Therapy. 18(1). 125–125. 16 indexed citations
9.
Erwin, William Mark, Leroi V. DeSouza, Martha Funabashi, et al.. (2015). The biological basis of degenerative disc disease: proteomic and biomechanical analysis of the canine intervertebral disc. Arthritis Research & Therapy. 17(1). 240–240. 39 indexed citations
10.
Erwin, William Mark, et al.. (2013). Chiropractors as Primary Spine Care Providers: precedents and essential measures.. PubMed Central. 17 indexed citations
11.
Rhee, John M., Mohammed F. Shamji, William Mark Erwin, et al.. (2013). Nonoperative Management of Cervical Myelopathy. Spine. 38(22 Suppl 1). S55–S67. 108 indexed citations
12.
Karadimas, Spyridon K., et al.. (2013). Pathophysiology and Natural History of Cervical Spondylotic Myelopathy. Spine. 38(22 Suppl 1). S21–S36. 300 indexed citations
13.
Erwin, William Mark. (2013). Biologically Based Therapy for the Intervertebral Disk: who is the Patient?. Global Spine Journal. 3(3). 193–199. 8 indexed citations
14.
Erwin, William Mark, et al.. (2012). Intervertebral Disc-Derived Stem Cells. Spine. 38(3). 211–216. 64 indexed citations
15.
Haldeman, Scott, Deborah Kopansky-Giles, Eric L. Hurwitz, et al.. (2012). Advancements in the Management of Spine Disorders. Best Practice & Research Clinical Rheumatology. 26(2). 263–280. 72 indexed citations
16.
Heras, Facundo Las, Ralph S. DaCosta, Kenneth P. H. Pritzker, et al.. (2011). Aberrant axial mineralization precedes spinal ankylosis: a molecular imaging study in ank/ankmice. Arthritis Research & Therapy. 13(5). R163–R163. 2 indexed citations
17.
Erwin, William Mark, Diana Islam, Robert D. Inman, Michael G. Fehlings, & Florence W. L. Tsui. (2011). Notochordal cells protect nucleus pulposus cells from degradation and apoptosis: implications for the mechanisms of intervertebral disc degeneration. Arthritis Research & Therapy. 13(6). R215–R215. 127 indexed citations
18.
Erwin, William Mark. (2008). The Notochord, Notochordal cell and CTGF/CCN-2: ongoing activity from development through maturation. Journal of Cell Communication and Signaling. 2(3-4). 59–65. 32 indexed citations
19.
Erwin, William Mark & Robert D. Inman. (2006). Notochord Cells Regulate Intervertebral Disc Chondrocyte Proteoglycan Production and Cell Proliferation. Spine. 31(10). 1094–1099. 101 indexed citations
20.
Erwin, William Mark, et al.. (2000). Innervation of the human costovertebral joint: Implications for clinical back pain syndromes. Journal of Manipulative and Physiological Therapeutics. 23(6). 395–403. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert A. Hartman Breakdown of academic impact, for papers by Markus Kroeber Breakdown of academic impact, for papers by Devina Purmessur Breakdown of academic impact, for papers by D. C. Jaffray Breakdown of academic impact, for papers by N Chiverton Breakdown of academic impact, for papers by Yoichi Aota Breakdown of academic impact, for papers by Jayesh Trivedi Breakdown of academic impact, for papers by Johanna Virri Breakdown of academic impact, for papers by Yasuo Kokubo Breakdown of academic impact, for papers by John C. Y. Leong
Rankless by CCL
2026